This company listing is no longer active
Jacobio Pharmaceuticals Group Balance Sheet Health
Financial Health criteria checks 5/6
Jacobio Pharmaceuticals Group has a total shareholder equity of CN¥1.3B and total debt of CN¥60.0M, which brings its debt-to-equity ratio to 4.8%. Its total assets and total liabilities are CN¥1.6B and CN¥332.3M respectively.
Key information
4.8%
Debt to equity ratio
CN¥60.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.30b |
| Equity | CN¥1.26b |
| Total liabilities | CN¥332.28m |
| Total assets | CN¥1.60b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1167's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥202.9M).
Long Term Liabilities: 1167's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥129.4M).
Debt to Equity History and Analysis
Debt Level: 1167 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 1167's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1167 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1167 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 45.9% each year.